The UK Pharmacy Access Report 2026

Community pharmacy policy and market commentary often begin with a single number — how many contractors are on a register. That count matters, but it does not describe where those pharmacies sit relative to where people live. This report starts with location.

We include 12,503 eligible physical community pharmacies in the certified universe, of which 12,502 are geocoded for distance work. One eligible England pharmacy (FCW02) lacks a usable frozen coordinate; it remains in eligibility totals but not in D1/D2/D3 calculations.

Population is represented through 46,844 official small areas: Lower Layer Super Output Areas in England and Wales, Data Zones in Scotland, and Data Zones in Northern Ireland. Each area carries a resident population from its source vintage. We weight national and regional summaries by those populations.

Because nations use different area vintages and population years, we report nation-level and within-nation council metrics. We do not blend populations into a synthetic UK proximity index.

Pharmacies in this report are eligible physical community sites on a harmonised inclusion list. Mail-order-only, hospital-only and other excluded categories are out of scope. That boundary keeps the geography comparable across nations even where contractual labels differ on the ground.

Each nation supplies its own small-area geography and population vintage. England and Wales share LSOA-style areas; Scotland and Northern Ireland use Data Zones. The counts are large enough that national medians are stable, but readers comparing councils should stay within the same nation.

Straight-line kilometres are not a policy prescription for how people collect prescriptions. They are a reproducible distance rule that scales to 46,844 areas. Where this report says a population share is ‘within three kilometres’, it means the centroid of the small area lies within that radius of at least one eligible pharmacy.

The inaugural 2026 edition establishes a baseline. Future editions can apply the same methodology and eligibility rules to show how pharmacy supply and geographic proximity change over time.

Nearest-pharmacy distance (D1) answers the simplest descriptive question: how far is the closest eligible site from the centroid of a small population geography? It is intuitive for readers and stable for year-on-year comparison when eligibility rules are held constant.

National medians for England and Scotland are close in this edition. Wales sits higher. Northern Ireland’s median lies between — but medians alone would miss Wales’s longer tail, which we take up in the next chapter.

We also report population shares within one, three, five and ten kilometres. These bands help readers who think in policy radii rather than kilometres of median distance.

England’s scale dominates the pharmacy numerator, but Scotland’s land mass and Wales’s rurality shape denominators and tails differently. Northern Ireland’s compact geography interacts with corridor settlement in ways a single median cannot summarise.

When we compare nations side by side, we show certified metrics only. The UI does not compute a synthetic UK median because population years differ. That constraint is intentional: a blended headline would imply more precision than the underlying vintages support.

Readers familiar with dispensing statistics should expect proximity and volume to diverge. A busy urban pharmacy can sit close to many centroids while a quiet rural branch may be the only site for a wide catchment. This report measures the latter structure, not footfall.

A national median can look reassuring while a non-trivial share of represented population sits in small areas far from any pharmacy. Policy audiences often care about tails as much as centres.

Shares beyond five and ten kilometres, and resident counts represented in those tails, describe how much of each nation’s population is represented by small areas whose centroids lie farther from the nearest eligible pharmacy — not how many people personally travel that distance.

Wales shows the largest beyond-five-kilometre share among the four nations in UK-PAR-2026. That result deserves careful wording: it is a geographic pattern in certified data, not a clinical access verdict.

Tail metrics complement medians the way variance complements a mean. A nation with a moderate median can still register material population represented beyond five kilometres if rural areas pull the distribution.

We report both shares and resident counts represented in tail bands. Shares aid comparison; counts ground the scale of represented population in each nation’s own demographic totals.

Interpreting tails requires the centroid caveat. A large LSOA with a centroid far from a pharmacy can contain neighbourhoods closer to a site. We do not disaggregate below official geography in this edition.

Pharmacies per 10,000 residents measures how many eligible sites serve a nation’s resident population on paper. Within-three-kilometre share measures the proportion of the population represented by small areas whose centroids lie within three kilometres of an eligible pharmacy.

The two metrics move together only loosely. Northern Ireland registers the highest pharmacies per 10,000 in this edition while England shows a higher within-three-kilometre share. Urban clustering, coastlines, islands and rural dispersion all shape the gap.

We do not infer causation from these cross-sectional comparisons. We use them to stop a single supply statistic standing in for a geographic story.

Supply per 10,000 uses nation resident populations from the certified pipeline, not GP list sizes or dispensing patients. It is a coarse intensity measure suited to headline comparison, not branch economics.

The scatter view in this chapter places each nation once. It is descriptive geometry, not a fitted model. Outliers in policy space are often nations with different settlement patterns rather than ‘errors’.

D2 and D3 ask a different question from D1: how far are the second and third nearest pharmacies? A community can be geographically close to one pharmacy while its second- and third-nearest alternatives are materially farther away.

Population-weighted medians rise from D1 to D2 to D3 in every nation. The step sizes differ — Wales shows particularly wide gaps, consistent with its longer national D1 and rural structure.

Alternative-pharmacy distance matters for resilience narratives — temporary closure, delivery pressure, or patient choice — but this report does not model behaviour. We only describe how far centroids sit from the second and third nearest eligible sites.

Where D2 and D3 jump sharply, readers should pair those charts with the regional explorer: council medians often explain national step sizes.

Councils and local authorities are the level at which many readers locate themselves. We rank areas within each nation — never as a single UK league table — on median D1, tail shares, supply per head and alternative-pharmacy distances.

Use the explorer to search by name, switch metrics and compare highest and lowest areas on the selected measure.

Within-nation ranking avoids implying that a Scottish council is directly comparable to an English district on raw rank. Populations, area sizes and naming conventions differ.

Search helps long official names. Sorting by tail share rather than median D1 often surfaces rural authorities that national headlines obscure.

The map plots certified small-area centroids, coloured by D1. These are population geography centre points used in the proximity calculation — not pharmacy premises and not household addresses.

This edition maps the population-area centroids used in the proximity analysis rather than full small-area boundaries.

Points represent population-area centroids used in the report's proximity calculation. They are not pharmacy locations unless a separate layer is added in a future edition.

Colour encodes certified D1 for each centroid. Dense urban cores may overlap visually; zoom and nation switching clarify structure. Map data loads per nation to keep initial page weight lower.

Where deprivation indices align with geography vintages, we relate median D1 to deprivation deciles. England has full population linkage in this edition. Wales and Northern Ireland are partial. Scotland is unavailable because SIMD geography does not match the frozen small-area vintage — we explain rather than chart zeros.

Deprivation deciles summarise socio-economic context at small-area level. Relating them to median D1 is exploratory: correlation is not causation, and indices measure multiple domains beyond health access.

England’s IMD linkage is complete for represented population in this edition. Wales’s WIMD linkage is high but not universal — treat charts as covering most, not all, of the represented population.

Northern Ireland’s partial NIMDM linkage means decile patterns may not generalise. Scotland is omitted where SIMD geography does not align with frozen Data Zones — absence of a chart is a methodology statement, not a zero finding.

England contributes the majority of eligible pharmacies and small areas. National within-three-kilometre shares are high relative to other nations, but council-level medians span dense cities and sparse districts.

Index of Multiple Deprivation linkage is complete for this edition, supporting the England deprivation section.

London and major metropolitan cores compress median D1 at council level, while upland and coastal districts extend tails. England’s large denominator makes national shares look favourable even when individual authorities face long centroid distances.

Full IMD linkage allows readers to ask whether more deprived deciles show systematically different median D1 in this cross-section. Answers are edition-specific and should be read beside methodology limits.

England also carries the FCW02 coordinate exclusion. National proximity metrics slightly undercount eligible sites by one pharmacy; eligibility totals retain the site.

Scotland’s national median D1 is similar to England’s, yet tail shares and council geography differ. Island and Highland patterns pull individual areas far from the national centre.

SIMD deprivation linkage is not published here because of geography vintage mismatch — not because linkage is zero.

Scotland’s similarity to England on national median D1 coexists with a larger beyond-ten-kilometre share in certified data — a reminder that medians and tails tell different stories.

Island councils and Highland areas frequently appear at the extreme of within-nation rankings. Official small-area geographies and centroids follow the published statistical boundaries for each council.

Without SIMD in this edition, Scotland’s deprivation chapter is intentionally blank. Editorial copy should not imply equal access or zero deprivation linkage.

Wales combines the longest national median D1, the largest beyond-five-kilometre population share, and elevated D2/D3 medians. Rural Powys and coastal communities appear frequently at the top of within-nation distance rankings.

Welsh Index of Multiple Deprivation analysis is shown with explicit partial population coverage (~95% in certified metadata).

Wales is the standout nation on median D1 and beyond-five-kilometre share in UK-PAR-2026. Powys and other large rural authorities drive much of the tail structure; South Wales valleys show different proximity patterns.

Elevated D2 and D3 medians mean alternatives are farther even when a first pharmacy exists. That pattern is consistent across charts and council tables.

WIMD coverage at roughly ninety-five percent means deprivation charts describe most represented population, but edge cases near linkage boundaries should not be over-interpreted.

Northern Ireland leads on pharmacies per 10,000 residents while showing a lower within-three-kilometre share than England. Settlement along corridors and coasts concentrates supply differently from population centroids.

NIMDM deprivation linkage covers only a minority of represented population (~22.5%). Treat that section as exploratory.

High pharmacies per 10,000 reflect Northern Ireland’s population scale and pharmacy count jointly. Within-three-kilometre shares reflect settlement patterns, population distribution and how pharmacies are spread across the nation — not travel time or road distance.

Within-three-kilometre share sits below England’s despite leading supply intensity. The supply-versus-proximity chapter is written with Northern Ireland in mind.

Limited NIMDM coverage requires cautious language. Use the banner on the deprivation section before drawing policy conclusions.

Eligible pharmacies are physical community sites meeting UK-PAR-2026 inclusion rules applied uniformly before geocoding. Distances are straight-line from official centroids. D1, D2 and D3 use the nearest three distinct eligible sites.

Population weighting uses resident counts attached to each small area in its source vintage. The 2026 report uses a frozen analytical dataset so published figures remain reproducible. The source register notes where individual dataset provenance remains incomplete.

Geographic coordinates are frozen within each report edition; later corrections are incorporated through a revised or subsequent edition.

The source register records the datasets used to construct the report.

Published figures are generated from the frozen analytical dataset for the 2026 edition. Editorial commentary is written around those fixed values.